Washington Trust Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-380
| Closed | -$221K | – | 222 |
|
|
2024
Q1 | $221K | Sell |
380
-590
| -61% | -$331K | 0.02% | 209 |
|
|
2023
Q4 | $515K | Buy |
970
+34
| +4% | +$16.5K | 0.05% | 136 |
|
|
2023
Q3 | $474K | Buy |
936
+220
| +31% | +$117K | 0.05% | 130 |
|
|
2023
Q2 | $374K | Sell |
716
-234
| -25% | -$126K | 0.04% | 154 |
|
|
2023
Q1 | $548K | Sell |
950
-572
| -38% | -$322K | 0.06% | 120 |
|
|
2022
Q4 | $839K | Sell |
1,522
-20,627
| -93% | -$10.9M | 0.1% | 103 |
|
|
2022
Q3 | $11.2M | Sell |
22,149
-180
| -0.8% | -$101K | 1.43% | 20 |
|
|
2022
Q2 | $12.1M | Sell |
22,329
-293
| -1% | -$161K | 1.56% | 17 |
|
|
2022
Q1 | $13.4M | Sell |
22,622
-155
| -0.7% | -$89K | 1.55% | 22 |
|
|
2021
Q4 | $15.2M | Sell |
22,777
-346
| -1% | -$216K | 1.47% | 22 |
|
|
2021
Q3 | $13.2M | Buy |
23,123
+306
| +1% | +$168K | 1.54% | 19 |
|
|
2021
Q2 | $11.5M | Sell |
22,817
-147
| -0.6% | -$69.4K | 1.36% | 22 |
|
|
2021
Q1 | $10.5M | Buy |
22,964
+111
| +0.5% | +$53K | 1.29% | 23 |
|
|
2020
Q4 | $10.6M | Sell |
22,853
-1,470
| -6% | -$689K | 1.39% | 18 |
|
|
2020
Q3 | $10.7M | Sell |
24,323
-2,647
| -10% | -$1.09M | 1.59% | 10 |
|
|
2020
Q2 | $9.77M | Sell |
26,970
-343
| -1% | -$115K | 1.55% | 12 |
|
|
2020
Q1 | $7.75M | Sell |
27,313
-675
| -2% | -$213K | 1.49% | 16 |
|
|
2019
Q4 | $9.09M | Sell |
27,988
-1,122
| -4% | -$340K | 1.29% | 20 |
|
|
2019
Q3 | $8.48M | Sell |
29,110
-1,763
| -6% | -$505K | 1.39% | 19 |
|
|
2019
Q2 | $9.07M | Sell |
30,873
-2,681
| -8% | -$738K | 1.47% | 15 |
|
|
2019
Q1 | $9.18M | Sell |
33,554
-48
| -0.1% | -$11.9K | 1.46% | 13 |
|
|
2018
Q4 | $7.52M | Buy |
33,602
+345
| +1% | +$80.9K | 0.99% | 29 |
|
|
2018
Q3 | $8.12M | Sell |
33,257
-1,800
| -5% | -$414K | 1.21% | 21 |
|
|
2018
Q2 | $7.26M | Buy |
35,057
+725
| +2% | +$154K | 1.01% | 25 |
|
|
2018
Q1 | $7.09M | Buy |
34,332
+300
| +0.9% | +$63K | 1.02% | 29 |
|
|
2017
Q4 | $6.46M | Buy |
34,032
+2,143
| +7% | +$411K | 0.95% | 32 |
|
|
2017
Q3 | $6.03M | Buy |
31,889
+29,904
| +1,506% | +$5.42M | 0.96% | 31 |
|
|
2017
Q2 | $346K | Sell |
1,985
-225
| -10% | -$37.8K | 0.07% | 148 |
|
|
2017
Q1 | $339K | Buy |
2,210
+10
| +0.5% | +$1.53K | 0.07% | 157 |
|
|
2016
Q4 | $310K | Sell |
2,200
-43
| -2% | -$6.34K | 0.07% | 154 |
|
|
2016
Q3 | $357K | Buy |
2,243
+32
| +1% | +$4.93K | 0.09% | 134 |
|
|
2016
Q2 | $327K | Buy |
2,211
+901
| +69% | +$133K | 0.08% | 131 |
|
|
2016
Q1 | $185K | Sell |
1,310
-225
| -15% | -$30.2K | 0.05% | 183 |
|
|
2015
Q4 | $218K | Sell |
1,535
-85
| -5% | -$11.3K | 0.05% | 188 |
|
|
2015
Q3 | $198K | Sell |
1,620
-1,716
| -51% | -$224K | 0.05% | 192 |
|
|
2015
Q2 | $433K | Sell |
3,336
-50
| -1% | -$6.52K | 0.11% | 118 |
|
|
2015
Q1 | $455K | Sell |
3,386
-125
| -4% | -$16.1K | 0.11% | 123 |
|
|
2014
Q4 | $440K | Buy |
3,511
+795
| +29% | +$96.7K | 0.11% | 136 |
|
|
2014
Q3 | $331K | Sell |
2,716
-70
| -3% | -$8.51K | 0.1% | 160 |
|
|
2014
Q2 | $329K | Sell |
2,786
-15
| -0.5% | -$1.76K | 0.07% | 170 |
|
|
2014
Q1 | $337K | Buy |
+2,801
| New | +$333K | 0.07% | 159 |
|
Other funds holding TMO
Washington Trust Bank's TMO Position: Q2 2024 in Review
Washington Trust Bank sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 380 shares — an estimated $221K sold.
Washington Trust Bank first reported a position in TMO in Q1 2014 and held it in 41 quarters. The position peaked at $15.2M in Q4 2021. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.
- Washington Trust Bank reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
- Washington Trust Bank sold 380 Thermo Fisher Scientific shares in Q2 2024, an estimated $221K.
- Washington Trust Bank first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 41 quarters.
- Washington Trust Bank's Thermo Fisher Scientific position peaked at $15.2M in Q4 2021.
- 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.
Based on Washington Trust Bank's 13F filing for Q2 2024, filed 29 Jul 2024.